PETMED EXPRESS INC (PETS) — SEC Financial Statements & Analysis

PETMED EXPRESS INC (PETS) is a retail-drug stores and proprietary stores company, incorporated in FL. PETMED EXPRESS INC trades on Nasdaq as: PETS. PETMED EXPRESS INC (PETS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, PETMED EXPRESS INC carries a market cap of $41.63M, a P/E ratio of -1.42x, a P/B ratio of 1.81x, a P/S ratio of 0.25x, an enterprise value of $28.55M, and an EV/EBITDA multiple of -1.33x. On profitability, it posts a gross margin of 27.92%, an operating margin of -18.22%, a net margin of -17.34%, a Return on Equity (ROE) of -78.56%, a Return on Assets (ROA) of -33.73%, and a Return on Invested Capital (ROIC) of -219.72%. Per share, it reports EPS of $-1.35, diluted EPS of $-1.35, free cash flow per share of $-1.28, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -20.33% year-over-year, net income growth of -33.72% year-over-year, and EPS growth of -36.56% year-over-year. On the balance sheet, it maintains a current ratio of 0.68x, a quick ratio of 0.37x, working capital of $-12.99M, a debt-to-equity ratio of 1.77x, a debt ratio of 0.64, an interest coverage ratio of -14.37x, free cash flow of $-27.82M (TTM), and net debt of $-13.08M. Figures sourced from SEC EDGAR.

Market Cap

$41.63M

P/E TTM

-1.42x

EPS TTM

$-1.35

P/B TTM

1.81x

ROE TTM

-78.56%

ROA TTM

-33.73%

Debt To Equity

1.77x

Free Cash Flow TTM

$-27.82M

Net Revenue TTM Growth 1Y

-20.33%

Data as of 2026-06-30 · Source: SEC EDGAR